# Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults

> **NCT01865968** · PHASE4 · COMPLETED · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 239 (actual)

## Conditions studied

- Hepatitis A

## Interventions

- **BIOLOGICAL:** Inactivated HAV vaccine
- **BIOLOGICAL:** Live attenuated HAV vaccine

## Key facts

- **NCT ID:** NCT01865968
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-09
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2015-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865968, "Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01865968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*